Perspectives on Healthcare Access and Equity of People With Parkinson's Disease Identifying as LGBTQ+ (LGBTQ+_PD)

January 30, 2023 updated by: Tara McIsaac, Creighton University

Perspectives on Healthcare Access and Equity of People With Parkinson's Disease Identifying as Lesbian, Gay, Bisexual, Transgender, Questioning, Intersex, or Two-spirit

Study Rationale:

Older adults who identify as lesbian, gay, bisexual, transgender, or queer (LGBTQ+) have worse health than non-LGBTQ+ older adults. They and their care partners face greater barriers to getting healthcare and support from friends and family. This is because of lifelong stigma, discrimination, and isolation often separated from their families. Parkinson disease (PD) is a disease that usually appears in older age, so there may be many LGBTQ+ elders with PD, but there is currently no information on how people with PD who are LGBTQ+ are coping with their disease and aging. This study will begin to clarify their needs.

Hypothesis/Research Question:

What are the experiences and perspectives of LGBTQ+ people living with PD, their care partners, and physicians managing people with PD?

Study Design:

The investigators will interview 20 people with PD, half who identify as LGBTQ+ and half who are not. The investigators will also interview their care partners and physicians who treat people with PD. From the responses to the interview questions, investigators will create a survey that will be sent to people across the country.

Impact on Diagnosis/Treatment of Parkinson's Disease:

By understanding what LGBTQ+ people with PD need, and what ideas they have for improving their healthcare, better systems for meeting their needs can be built.

Next Steps for Development:

With this understanding, future work can focus on educating healthcare providers and clinics to improve the ways they talk with and treat LGBTQ+ people with PD.

Study Overview

Detailed Description

This mixed-methods study has a qualitative study component (1) and a quantitative study component (2):

Component 1) using a phenomenological inductive approach and Grounded Theory methodology the investigators will find and build themes from semi-structured interviews and focus groups with a) LGBTQ+ and non-LGBTQ+ individuals with PD, b) their care partners, and c) physicians to identify the experiences and perspectives on their health care and participation in research.

Component 2) survey development informed by results of Component 1, national distribution, and analysis of LGBTQ+ and non-LGBTQ+ people with PD, their caregivers and physicians, on barriers and access to health and disease information, healthcare delivery and participation in research.

The investigators plan to recruit 10 LGBTQ+ individuals with PD, 10 Non-LGBTQ+ individuals with PD, 10 care partners, and 10 healthcare providers for individual interviews, and 50 LGBTQ+ older adults with PD and care partners for focus groups consisting of 6-8 individuals each. For the national electronic survey investigators estimate needing a the sample size of approximately 380 responses calculated using a 95% confidence level (Z score=1.96), a standard deviation of .5, a 5% margin of error, and a population of 30,000. Purposive and Snowball sampling methods (nonprobability sampling) will be used.

Study Type

Observational

Enrollment (Anticipated)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Individuals from across the United States, from urban and rural areas and across diverse socioeconomic environments, with online access for a 2-hour period on a single day.

Description

Inclusion Criteria:

  • Diagnosed with PD
  • Care partner of someone diagnosed with PD
  • Health Care Provider providing services to individuals with PD
  • Identify as LGBTQ+
  • Identify as Non-LGBTQ+

Exclusion Criteria:

  • Non-English speaking
  • Inability to communicate via video conferencing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
LGBTQ+_PD
Individuals who identify as LGBTQ+ and are diagnosed with PD
One on One interviews by Zoom video conferencing, < 2 hours in duration
Focus Groups discussions by Zoom video conferencing, < 2 hours in duration
Survey conducted online and distributed nationally
Non-LGBTQ_PD
Individuals who identify as non-LGBTQ+ and are diagnosed with PD
One on One interviews by Zoom video conferencing, < 2 hours in duration
Focus Groups discussions by Zoom video conferencing, < 2 hours in duration
Survey conducted online and distributed nationally
Care Partner
Individuals who are Care Partners of individuals with PD
One on One interviews by Zoom video conferencing, < 2 hours in duration
Focus Groups discussions by Zoom video conferencing, < 2 hours in duration
Survey conducted online and distributed nationally
Health Care Provider
Health Care Providers who provide service to people with PD
One on One interviews by Zoom video conferencing, < 2 hours in duration
Focus Groups discussions by Zoom video conferencing, < 2 hours in duration
Survey conducted online and distributed nationally

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Themes of Lived Experience Accessing Health Care Services
Time Frame: 2 hours
Inductive and iterative thematic analysis of transcripts
2 hours
Themes of Lived Experience Providing Health Care Services to LGBTQ+ people with PD
Time Frame: 2 hours
Inductive and iterative thematic analysis of transcripts
2 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tara L McIsaac, PT, PhD, Creighton University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 18, 2022

Primary Completion (Anticipated)

October 1, 2023

Study Completion (Anticipated)

October 1, 2024

Study Registration Dates

First Submitted

August 12, 2022

First Submitted That Met QC Criteria

August 12, 2022

First Posted (Actual)

August 16, 2022

Study Record Updates

Last Update Posted (Actual)

February 1, 2023

Last Update Submitted That Met QC Criteria

January 30, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Individual interviews

3
Subscribe